Tekmira Pharma (TKMR) Posts Wider than Expected Q2 Loss of 28c/Share; Expects FDA Hold to Resolved by Q4 2014

Go back to Tekmira Pharma (TKMR) Posts Wider than Expected Q2 Loss of 28c/Share; Expects FDA Hold to Resolved by Q4 2014
TEKMIRA PHARM (NASDAQ: TKMR) Delayed: 10.83 --0 (-0%)
Previous Close $10.83    52 Week High $29.93 
Open $0.00    52 Week Low $10.02 
Day High $10.83    P/E N/A 
Day Low $10.83    EPS $0.00 
Volume 556,335